Polyporus Decoction clinical observation of malignant ascites_0.doc

 PAGE \* MERGEFORMAT 9 Polyporus Decoction clinical observation of malignant ascites [Keywords:] Zhulingtang, malignant ascites, peritoneal perfusion Malignant ascites is a serious complication of advanced malignant tumors, intractable, 1-year survival rate lt;10% [1]. Effective control of ascites in patients to improve quality of life and prolong survival is important. Peritoneal perfusion as an option of regional treatment, the high local drug concentration, systemic adverse reactions, in recent years has been widely used in clinical treatment of malignant ascites. However, unlike other benign ascites carcinoma ascites, the peritoneal fluid and peritoneal perfusion while pumping can be term effect achieved, but easy to repeated, long-term prognosis still optimistic. I used Polyporus Decoction received good effect of malignant ascites, is reported below. 1 Materials and Methods 1.1 General Information Observe the subjects in May 2006 -2008 in May of Traditional Chinese Medicine University, Department of Oncology, First Affiliated Hospital of hospitalized patients. A total of 80 patients with advanced malignant tumors were confirmed by histopathological examination cancer, confirmed by the B- a line or massive ascites and abdominal paracentesis inspection confirmed malignant ascites. observation group of 40 patients, 22 males and 18 females, median age 55 years, the amount of ascites in 23 cases, massive ascites in 17 cases, 10 cases of liver cancer and lung cancer in 7 cases, 7 cases of colorectal cancer, ovarian cancer, 8 cases of gastric cancer in 5 cases, the other 3 patients. control group of 40 patients, 23 males and 17 females, median age 53.5 years, the amount of ascites in 21 cases of massive ascites 19 cases, 9 cases of liver cancer, lung cancer in 8 cases, 7 cases of rectal cancer, 10 cases of ovarian cancer, gastric cancer in 4 cases, the other 2 cases, 2 groups generally no significant difference between data (Pgt; 0.05), comparable.